109 results
SC TO-C
EX-99.2
CTIC
CTI BioPharma Corp
10 May 23
Information about tender offer
5:01pm
for Sobi Differentiated asset by clinical data and mode of action in an area of unmet medical need Highly skilled workforce in the area of Haemato …
Differentiated asset by clinical data and mode of action in an area of unmet medical need Highly skilled workforce in the area of Haemato-Oncology Significant
SC14D9C
EX-99.1
CTIC
CTI BioPharma Corp
10 May 23
Written communication relating to third party tender offer
2:02pm
talented, passionate and innovative minds in hematology-oncology, a workforce they intend to leverage for the success of the combined company.
Next
SC14D9C
EX-99.4
CTIC
CTI BioPharma Corp
10 May 23
Written communication relating to third party tender offer
2:02pm
a highly talented and innovative workforce it intends to leverage for the success of the combined company.
What happens to my CTI stock options and will my
424B5
h3d4 qg77jpw4
14 Feb 20
Prospectus supplement for primary offering
8:14am
424B5
g7gfb8kb7 d2v
15 Nov 19
Prospectus supplement for primary offering
4:12pm
8-K
EX-99.1
w2ial
2 May 19
CTI BioPharma Reports First Quarter 2019 Financial Results
4:26pm
8-K
EX-99.1
nfgud8jlhvt
13 Mar 19
CTI BioPharma Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Highlights
4:17pm
8-K
EX-1
iwtb 5izr
3 Jan 19
Regulation FD Disclosure
4:37pm
8-K
EX-99.1
zls05
18 Dec 18
CTI BioPharma Provides Program Update Following Regulatory Feedback from the U.S. FDA on Pacritinib Development
4:49pm
8-K
EX-99.1
57ypdyepp2yp z0dn
13 Dec 18
CTI BioPharma Announces Restructuring Plan
5:15pm
8-K
1shvz0yj2yb
13 Dec 18
CTI BioPharma Announces Restructuring Plan
5:15pm